Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients

Stroke Clinical Trial

— ISOKINETIC  

Official title:

Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02917850
• Other study ID #: 2015_32
• Secondary ID: 2016-A00366-45
• Status: Withdrawn
• Phase: N/A
• Start date: August 2016
• Est. completion date: July 2018

Study information

• Verified date: September 2018
• Source: University Hospital, Lille
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Post-stroke patients often present with gait disorders due to several physical impairments. Hip flexor deficit is one of the more prevalent trouble and is associated with gait capacities. This study aims at evaluating the impact of an isokinetic hip flexors strengthening rehabilitation program in the subacute phase after stroke. Patients will be randomized to an intervention group (isokinetic rehabilitation) or a control group (conventional rehabilitation) and assessed at the end of the rehabilitation program, at 3 and at 6 months.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: July 2018
• Est. primary completion date: July 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients suffering from a first ever stroke

• At the subacute phase

• Able to walk at least 10m with or without assistive devices

• Hip flexors strength on the paretic side > 2/5 (MRC)

Exclusion Criteria:

• Uncontrolled epilepsy

• Contraindications to physical activity (severe arterial hypertension, aortic valvulopathy, severe PAD...)

• History of muscular or joint disorders on the paretic hip

• Subject unable to deliver an informed written consent (due to aphasia, cognitive or psychiatric disorders...)

• Protected persons

• Pregnancy

Related Conditions & MeSH terms

• Gait
• Hemiplegia
• Stroke

Intervention

Procedure:
• Isokinetic hip flexors strengthening
Isokinetic excentric strengthening of paretic hip flexors, 3/w during 6 weeks, in addition to conventional rehabilitation 7/w.
• Conventional rehabilitation
Conventional rehabilitation 10/w during 6 weeks

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Lille

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Max gait speed (m/s)	Gait speed will be assessed in the 10m walk test	6 weeks
Secondary	Max gait speed (m/s)	Gait speed will be assessed in the 10m walk test	3 and 6 months
Secondary	Hip flexors strength	Hip flexors strength will be evaluated using an isokinetic dynamometer (concentric, 30°/s) and motor testing (medical research council)	6weeks; 3 and 6 months
Secondary	Gait endurance	Gait endurance will be assessed using the 6MWT	6 weeks; 3 and 6 months
Secondary	Gait capacities	Functional ambulation categories (FAC)	6 weeks; 3 and 6 months
Secondary	Balance and postural control	Postural Assessment for Stroke Scale (PASS)	6 weeks; 3 and 6 months
Secondary	Balance and postural control	Timed-up and go test	6 weeks; 3 and 6 months
Secondary	Rate of perceived exhaustion during gait	Borg scale	6 weeks; 3 and 6 months